Dr. Mension combines a solid medical background with high-level clinical experience and academic involvement, standing out for his human, up-to-date, and multidisciplinary approach to the treatment of breast cancer and gynecological oncology.
Academically, he holds a Doctorate in Medicine with honors (Cum Laude) from the University of Barcelona, with a thesis focused on genitourinary syndrome of menopause in breast cancer survivors—a field to which he has contributed both clinical and research perspectives. Additionally, he has postgraduate training in Breast Pathology and Senology, a Master’s in Hospital Management, a fellowship in breast oncologic surgery, and solid preparation in oncoplastic and reconstructive surgery, as well as research methodology.
His outstanding training is endorsed by the BRESO certification (European Breast Surgical Oncology Certification), which certifies him as a breast surgeon in accordance with the most demanding European standards.
In the research field, Dr. Mension has published scientific articles in specialized journals on gynecology and breast cancer, and participates regularly in international conferences related to breast surgery. His work focuses on the intersection between oncoplastic surgery and women’s health, areas in which he is also accredited as a researcher in women’s health and human reproduction.
Throughout his career, he has built a professional reputation based on surgical excellence, academic rigor, and an international outlook. His curriculum reflects a constant commitment to innovation in breast and gynecologic surgery, as well as to the comprehensive training of future specialists.
Background
Dr. Eduard Mension is a specialist in oncoplastic breast and gynecologic surgery, and has built a career that skillfully balances clinical practice, teaching, and research. He currently works as a surgeon at Hospital Clínic de Barcelona, where he also serves as secretary of the Breast Cancer Unit, one of the most internationally recognized centers in the field of breast oncology.
His training and experience include stays at world-renowned centers such as the MD Anderson Cancer Center in Houston and Guy’s and St. Thomas’ Hospital in London, where he perfected advanced techniques in breast and gynecological surgery. He also combines his clinical work with teaching, serving as a lecturer in Grade in Medicine and the Master’s in Breast Cancer at the University of Barcelona, passing on his specialty knowledge to new generations of professionals.
Education
BACHELOR'S DEGREE: Degree in Medicine and Surgery
Centre: University of Barcelona – Hospital Clínic. Year: 2015
MIR EXAM Year: 2016
Order number: 410
SPECIALISED TRAINING IN GYNAECOLOGY AND OBSTETRICS – HOSPITAL CLÍNIC DE BARCELONA
Observership en MD Anderson Cancer Center, Houston, Texas: Oncología Quirúrgica de Mama con el Dr. Kuerer – 2019
Observership en MD Anderson Cancer Center, Houston, Texas: Oncología Quirúrgica Ginecológica con el Dr. Ramirez – 2019
Observership en Guy's and St Thomas' NHS Foundation Trust, Londres, Reino Unido: Departamento de Cirugía Mamaria con el Dr. Kothari / Dr. Hamed – 2023
Postgraduate Diploma in Statistics in Health Sciences
2017 - 2019
University Autónoma de Barcelona
Master's Degree in Breast Pathology and Senology
2018–2020
University of Barcelona
Master's Degree in Hospital Management and Health Services
2020 - 2022
University of Barcelona
Specialisation diploma in oncoplastic breast cancer surgery: Dr Benigno Acea
2022
University of A Coruña
DOCTORATE
Doctoral thesis title: Genitourinary syndrome of menopause in patients with a history of breast cancer
University of Barcelona
2020–2023
Certifications and memberships
- BRESO Certified Breast Surgeon (European certification in breast cancer surgery)
- Member of the International Menopause Society (IMS)
- AECIMA – Spanish Association of Breast Surgeons
- Member of SESPM – Spanish Society of Senology and Breast Pathology Member
- SCOG – Societat Catalana Obstetricia i ginecologia
- Membership SEGO – Sociedad Española de Ginecología y Obstetricia
- Membership COMB – Col·legi Oficial de Metges de Barcelona
Teaching
and research activity
- Scientific publications on gynaecology and breast cancer
- Active participation in international conferences
- University professor and contributor to specialised medical training
- Accredited researcher in women’s health and human reproduction
Articles
Rodríguez-Díaz L, Zaragoza-Ballester P, Torras I, Mensión E, Cebrecos I, Cases X, Vega M, Cordón J, Ribera-Perianes J, Vidal-Sicart S; Clínic Barcelona Nuclear Medicine (CBNM) Group. Selective sentinel lymph node biopsy in breast cancer local recurrence. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2025 Sep 23:500232.
IF 1.6, Q3
Gomà C, Mollà M, Oses G, Sanfeliu E, Rodríguez-Hernández A, González-Farré B, Galván P, Sirenko V, Castillo O, Blasco P, Llop-Guevara A, Serra V, Ganau S, Úbeda B, Bargalló X, Cases C, Latorre-Musoll A, Martínez-Sáez O, Garcia-Fructuoso I, Gómez-Bravo R, Schettini F, Adamo B, Pascual T, Vidal M, Muñoz M, Laplana M, Cebrecos I, Mension E, Prat A, Brasó-Maristany F. Preoperative Radiation Therapy-Induced Molecular and Immune Modulation in Early-Stage Breast Cancer: Results From the YOUNGSTER trial. Int J Radiat Oncol Biol Phys. 2025 Aug 5:S0360-3016(25)06042-0.
IF 2.058, Q1
Macedo M, Agustí E, Ganau S, Úbeda B, Sitges C, Ribera-Perianes J, Oses G, Pascual T, Mension E, Vidal-Sicart S, Bargalló X. Preoperative localization of metastatic axillary lymph nodes using radioactive iodine seed before neoadjuvant chemotherapy. A one-step marking method for targeted axillary dissection. Eur J Nucl Med Mol Imaging. 2025 Jul 31.
Úbeda B, Mensión E, Ganau S, Sitges C, Macedo M, Gasior DM, Cebrecos I, Sanfeliu E, Bargalló X. Second-Look Ultrasound: When Things Are Not Always as They Seem. Ultrasound Q. 2025 May 13;41(2):e00715.
IF 0.288, Q3
Eduard Mension, Francisco Carmona, Silvia Vannuccini, Charles Chapron. Clinical signs and diagnosis of fibroids from adolescence to menopause. Fertil Steril. 2024 Jul;122(1):12-19
IF 6.6, Q1
Cebrecos I, Torras I, Castillo H, Pumarola C, Ganau S, Sitges C, Vidal-Sicart S, Schettini F, Sanfeliu E, Loinaz I, Garcia M, Oses G, Molla M, Vidal M, Mension E. Predicting Additional Metastases in Axillary Lymph Node Dissection After Neoadjuvant Chemotherapy: Ratio of Positive/Total Sentinel Nodes. Cancers (Basel). 2024 Oct 29;16(21):3638.
IF 4.4, Q2
Schettini F, Brasó-Maristany F, Pascual T, Lorman-Carbó N, Nucera S, Bergamino M, Galván P, Conte B, Seguí E, García Fructuoso I, Gómez Bravo R, Rodríguez AB, Martínez-Sáez O, Chic N, Vidal M, Adamo B, González-Farre B, Sanfeliu E, Cebrecos I, Mensión E, Oses G, Locci M, Mollà M, Ganau S, Jares P, Vidal-Sicart S, Muñoz M, Prat A. Identifying predictors of treatment response and molecular changes induced by neoadjuvant chemotherapy and endocrine therapy in hormone receptor-positive/HER2-negative breast cancer: the NEOENDO translational study. ESMO Open. 2024 Dec;9(12):103989.
IF 3.582, Q1
Schettini F, Nucera S, Brasó-Maristany F, De Santo I, Pascual T, Bergamino M, Galván P, Conte B, Seguí E, García Fructuoso I, Gómez Bravo R, Rivera P, Rodríguez AB, Martínez-Sáez O, Ganau S, Sanfeliu E, González-Farre B, Vidal Losada MJ, Adamo B, Cebrecos I, Mension E, Oses G, Jares P, Vidal-Sicart S, Mollà M, Muñoz M, Prat A. Unraveling the clinicopathological and molecular changes induced by neoadjuvant chemotherapy and endocrine therapy in hormone receptor-positive/HER2-low and HER2-0 breast cancer. ESMO Open. 2024 Jul;9(7):103619.
IF 3.582, Q1
Marta Valdés-Bango, Meritxell Gracia, Elisa Rubio, Andrea Vergara Climent Casals-Pascual, Cristina Ros, Mariona Rius, Maria Ángeles Martínez-Zamora, Eduard Mension, Lara Quintas, Francisco Carmona. Comparative analysis of endometrial, vaginal, and gut microbiota in patients with and without adenomyosis. Acta Obstet Gynecol Scand. 2024 Jul;103(7):1271-1282.
IF: 3.5, Q1
Tortajada M, Agustí N, Fusté P, Mensión E, Díaz-Feijóo B, Glickman A, Marina T, Torné A. Laparoscopic
Fertility-Sparing Management of Borderline Ovarian Tumors: Surgical and Long-Term Oncological Outcomes.
J Clin Med. 2024 Sep 14;13(18):5458.
IF 2.9, Q2
Torras I, Cebrecos I, Castillo H, Rodríguez L, Zaragoza-Ballester P, Sitges C, Loinaz 1, Garcia M, Molla M,
Vidal-Sicart S, Mension E. Surgical Management and Its Impact on Adjuvant Treatment in Recurrent Ipsilateral Breast Cancer: A Retrospective Cohort Study. J Clin Med. 2024 Sep 14;13(18):5458.
IF 2.9. Q2
Inés Torras, Isaac Cebrecos, Helena Castillo, Eduard Mension. Evolution of breast conserving surgery-current implementation of oncoplastic techniques in breast conserving surgery: a literature review. Gland Surg. 2024 Mar 27;13(3):412-425.
IF 1.6, Q3
M. Macedo, S. Ganau, B. Úbeda et al., Magnetic resonance imaging findings for inflammatory mastitis
of unknown etiology, Radiología, 2024 Sep-Oct;66(5):410-418
IF 1.3, Q4
Ribera Torres L, Anglès-Acedo S, López Chardi L, Mension Coll E, Castelo-Branco C. Systemic testosterone
for the treatment of female sexual interest and arousal disorder (FSIAD) in the postmenopause. Gynecol Endocrinol. 2024 Dec;40(1):2364220.
IF 2.0, Q2
Eduard Mension Joaquim Calaf, Charles Chapron, Marie Madeleine Dolmans,Jacques Donnez, Louis Marcellin Felice Petraglia, Silvia Vannuccini, Francisco Carmona An update on the management of uterine fibroids: personalized medicine or guidelines? Journal of Endometriosis and Uterine Disorders 7 (2024) 100080
IF 0.0
Eduard Mension Joaquim Calaf, Charles Chapron, Marie Madeleine Dolmans,Jacques Donnez, Louis Marcellin Felice Petraglia, Silvia Vannuccini, Francisco Carmona An update on the management of uterine fibroids: personalized medicine or guidelines? Journal of Endometriosis and Uterine Disorders 7 (2024) 100080
IF 0.0
Mension E, Alonso I, Angles-Acedo S, et al. Effect of fractional carbon dioxide vs sham laser on sexual function in survivors of breast cancer receiving aromatase inhibitors for genitourinary syndrome of menopause: the LIGHT randomized clinical trial. JAMA Netw Open. 2023;6(2):e2255697.
IF: 10.5, Q1, D1
Oses, G.; Mension, E.; Pumarola, C.; Castillo, H.; Francesc, L.; Torras, I.; Cebrecos, I.; Caparrós, X.; Ganau, S.; Ubeda, B.; et al. Analysis of Local Recurrence Risk in Ductal Carcinoma In Situ and External Validation of the Memorial Sloan Kettering Cancer Center Nomogram. Cancers 2023, 15, 2392.
IF 4.4, Q2
* Co-primer author
Ros C, Mension E, Rius M, Munmany M, De Guirior C, Espuña-Pons M, Sònia Anglès, Camil Castelo-Branco. Assesing the vaginal wall thickness by transvaginal ultrasound in breast cancer survivors: a pilot study Maturitas, 2023.
IF 3.9, Q1
* Corresponding author
* Co-primer author
Cebrecos Isaac, Mension Eduard, Castillo Helena, Sanfeliu Esther, Vidal-Sicart Sergi, Ganau Sergi, Alonso Imma, Vidal Maria and Schettini Francesco. Non-sentinel axillary lymph-node status in clinically node-negative early breast cancer after primary systemic therapy and positive sentinel lymph-node: a predictive model proposal Ann Surg Oncol. 2023 Aug;30(8):4657-4668.
IF 3.5, Q1
Martínez-Zamora MA, Mension E, Martínez-Egea J, Peri L, Franco A, Gracia M, Ros C, Rius M, Carmona F. Risk factors for irreversible unilateral loss of renal function in patients with deep endometriosis. Sci Rep. 2023 Jul 24;13(1):11940.
IF 3.9, Q2
* Co-primer author
Carrillo Torres P, Martínez-Zamora MÁ, Ros C, Rius M, Mensión E, Gracia M, Carmona F. Clinical and sonographic impact of oral contraception in patients with deep endometriosis and adenomyosis at 2 years of follow-up. Sci Rep. 2023 Feb 4;13(1):2066.
IF 3.9, Q2
Castelo-Branco C, Mension E, Torras I, Cebrecos I, Anglès-Acedo S. Treating genitourinary syndrome of menopause in breast cancer survivors: main challenges and promising strategies. Climacteric. 2023 Aug;26(4):296-301.
IF 2.9, Q2
* Co-primer author
Mension E.,Castelo-Branco C., Laser in Gynecology, EGO European Gynecology and Obstetrics (2023); 2023/01:003 doi: 10.53260/EGO.235012
IF 0.0
Eduard Mension, Inmaculada Alonso, Marta Tortajada, Isabel Matas, Sílvia Gómez, Laura Ribera, Sònia Anglès, Camil Castelo-Branco, Vaginal laser therapy for genitourinary syndrome of menopause – systematic review. Maturitas. 2022 Feb;156:37-59.
IF 3.9, Q1
Carrillo P, Gorría T, Santana D, Sepulveda M, Aldecoa I, Gonzalez-Farré B, Sanfeliu E, Mension E, Cebrecos I, Martínez-Saez O, Alonso I, Saiz A: Aquaporin-4-Positive Triple-Negative Breast Cancer Presenting with Paraneoplastic Neuromyelitis Optica Spectrum Disorder. Biomed Hub 2022;7:11-16.
IF 3.3, Q2
* Corresponding author
E. Mension, I. Alonso, I. Cebrecos, N. Castrejon, M. Tortajada, I. Matas, S. Gómez, L. Ribera, S. Anglès-Acedo & C. Castelo-Branco (2022) Safety of prasterone in breast cancer survivors treated with aromatase inhibitors: the VIBRA pilot study. Climacteric. 2022 Oct;25(5):476-482.
IF 2.9, Q2
Castillo H, Mension E, Cebrecos I, Angles-Acedo S, Castelo-Branco C. Sexual Function in Breast Cancer Patients: A Review of the Literature. Clin. Exp. Obstet. Gynecol. 2022, 49(6), 134;
IF 0.6, Q4
* Corresponding author
Ros C, de Guirior C, Mension E, Rius M, Valdés-Bango M, Tortajada M, Matas I, Martínez-Zamora MÁ, Gracia M, Carmona F. Transvaginal ultrasound for the diagnosis of endometriosis in the uterosacral ligaments, torus uterinus and posterior vaginal fornix: a prospective study. Ultrasound Obstet Gynecol. 2021 Jun 5.
IF: 6.3, Q1
Mension E, Alonso I, Castelo-Branco C. Genitourinary Syndrome of Menopause: Current Treatment Options in Breast Cancer Survivors – Systematic Review. Maturitas. 2021 Jan;143:47-58.
IF 3.9, Q1
Larroya M, Tortajada M, Mensión E, Pauta M, Rodriguez-Revenga L, Borrell A. Have maternal or paternal ages any impact on the prenatal incidence of genomic copy number variants associated with fetal structural anomalies? PLoS One. 2021 Jul 9;16(7):e0253866.
IF: 3.0, Q2
Castelo-Branco C, Mension E. Are we assessing genitourinary syndrome of menopause properly? Climacteric. 2021 Dec;24(6):529-530.
IF 2.9, Q2
Mension E, Alonso I, Tortajada M, Matas I, Gómez S, Ribera L, Ros C, Anglès-Acedo S, Castelo-Branco C. Genitourinary Syndrome of Menopause Assessment Tools. J Midlife Health. 2021 Apr-Jun;12(2):99-102.
IF: 1.2, Q3
Rius M, Fusté P, Ros C, Martínez-Zamora Á, deGuirior C, Gracia M, Mension E, Carmona F. HE4 might be a more useful tumor biomarker to detect malignancy in patients with ovarian endometrioma when malignancy is suspected. J Int Med Res. 2021 Sep;49(9):3000605211047701.
IF 0.0
Mension E, Alonso I, Castelo-Branco C. Breast Cancer in Men: Clinical and Pathological Analysis of 19 Cases and Review of Literature. Journal of Obstetrics and Gynecological Problems, 2020, vol. 3, num. 1, p. 1-5 Nov 30, 2020
IF 0.0
Rodríguez-Trujillo A, Fusté P, Paredes P, Mension E, Agustí N, Gil-Ibáñez B, et al. Long-term oncological outcomes of patients with negative sentinel lymph node in vulvar cancer. Comparative study with conventional lymphadenectomy. Acta Obstet Gynecol Scand. 2018;97:1427–1437.
IF: 3.5, Q1
Awards
Award for best oral presentation at the Spanish Society of Senology and Breast Pathology conference (2022, Oviedo): Psychosocial variables in the treatment of vulvovaginal atrophy in female breast cancer survivors.
2021 Menopause Research Grant Award from the Spanish Foundation for the Study of Menopause, for the work: ‘Brain activation patterns in sexual desire-arousal disorders and in women with normal sexual function. Effects of menopause.’
Award for best oral presentation at the 15th Annual Congress of the European Association of Urogynaecology: Fractional carbon dioxide laser vs. sham laser in breast cancer survivors treated with aromatase inhibitors and with genitourinary syndrome of menopause. Short-term results of a randomised clinical trial.
Award for best poster at the European Society for Sexual Medicine Congress (2022): Sexual health in female breast cancer survivors with menopausal genitourinary syndrome: is it just a matter of dyspareunia?
Award for best oral presentation at the Spanish Society of Senology and Breast Pathology conference (2019, Madrid): SANA (Sentinel Node After Neoadjuvancy) multicentre study.
Research
Collaborating researchers: Sònia Anglès Acedo, Dr Inmaculada Alonso, Dr Laura Ribera, Dr Eduard Mensión Coll and Ms Míriam Redondo
Sponsor: FISS ISCIII. HCB/2019/0786. NCT04619485
Collaborating researchers: Dr Laura Ribera, Dr Eduard Mension Coll, Dr Isaac Cebrecós, Dr Sonia Anglès
Source of funding: LACER
Collaborating researchers: Dr Sonia Anglès, Dr Francisca Molero, Dr Laura Ribera, Dr Eduard Mensión Coll and Ms Míriam Redondo
Source of funding: SHIONOGI
Investigador colaborador: Dra. Francisca Molero, Dra. Laura Ribera, Dr. Eduard Mensión Coll y Sra. Míriam Redondo
Source of funding: SHIONOGI + ERDF aid
Collaborating researchers: Dr Francisca Molero, Dr Laura Ribera, Dr Camil Castelo-Branco and Ms Míriam Redondo.
Funding source: ARAFARMA
Funding source: TV3 Marathon Foundation
